ELREXFIO sol inj 44 mg/1.1ml flac 1.1 ml
7680686460010
CH-68646
L01F
07.16.1.
Reimbursement limitations:
ELREXFIO
Après garantie de prise en charge des coûts par l’assureur-maladie après consultation préalable du médecin-conseil.
…
1 / 2
google
Details
- Product number
- 6864601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- elranatamabum 44 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1.1 ml corresp. natrium 0.0074 mg.
Articles (1)
Elrexfio 44 mg/1.1 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
44.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.0074 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3125.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2024
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 68646
- Drug name
- Elrexfio, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01F
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 05/09/2023
- Authorization expiration date
- 30/06/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ELREXFIO sol inj 44 mg/1.1ml flac 1.1 ml
- Description (DE)
- ELREXFIO Inj Lös 44 mg/1.1ml Durchstf 1.1 ml
- Market launch
- 05/09/2023
- Narcotic (BTM)
- No